SHUTTLE PHARMACEUTICALS
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. While there are several therapies being developed with the goal of curing cancer, one of the most effective and proven approaches to this is radiation therapy (RT).
SHUTTLE PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.shuttlepharma.com
Total Employee:
11+
Status:
Active
Contact:
240-403-4212
Email Addresses:
[email protected]
Total Funding:
912.5 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Google Cloud Sectigo SSL Sectigo Domain SSL
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Checkmate Pharmaceuticals
Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.shuttlepharma.com Semrush global rank: 6.06 M Semrush visits lastest month: 1.34 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Shuttle Pharmaceuticals"
About Us - Shuttle Pharmaceuticals Inc
We are pioneering innovative therapies that target cancer cells, protect healthy tissue, and harness the body’s innate immune response. Our mission is to enhance the power of radiation …See details»
Leadership | Shuttle Pharmaceuticals
Shuttle Pharmaceuticals 401 Professional Drive Suite 260 Gaithersburg, MD 20879. 240-430-4212 [email protected]See details»
Shuttle Pharmaceuticals, Inc. | LinkedIn
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company developing novel therapies and diagnostics to improve the outcomes for cancer patients treated with radiation therapy.See details»
Shuttle Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Shuttle Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; …See details»
About SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Shuttlepharma.com Mark Founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharmaceuticals is a discovery and development stage specialty …See details»
Shuttle Pharmaceuticals Holdings - Overview, News & Similar
Apr 23, 2024 Who is Shuttle Pharmaceuticals Holdings. Shuttle Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company leveraging their proprietary technology to develop …See details»
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) - Yahoo Finance
See the company profile for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Shuttle Pharmaceuticals
5 days ago Our innovative therapies target cancer cells, protect healthy tissue, and harness the body’s innate immune response. Our mission is to enhance the power of radiation therapy …See details»
Shuttle Pharmaceuticals Holdings, Inc.
[email protected] . 2 Forward Looking Statements For illustrative purposes only. Past performance is not indicative of future results. An Investment in the Company’s …See details»
Shuttle Pharma Provides Corporate Update and Reports 2024
Feb 26, 2025 [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum 602-889-9700 [email protected] ...See details»
Shuttle Pharmaceuticals Expands Laboratory Space to Advance …
Feb 23, 2023 In November 2022, Shuttle announced it had engaged Theradex Oncology, a leading clinical research organization, to help prepare for its upcoming clinical study of …See details»
Shuttle Pharmaceuticals
Feb 25, 2025 www.shuttlepharma.com Dive deeper into fresh insights across Business , Industry Leaders and Influencers , Organizations , Education , and Investors for a comprehensive view. …See details»
Shuttle Pharmaceuticals Holdings Inc. - Cruelty Free Investing
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat …See details»
Shuttle Pharma - 2025 Company Profile & Funding - Tracxn
Mar 17, 2025 Shuttle Pharma - Developing therapies to improve outcome of radiation therapy in cancer suffering patients. Public Company. Raised a total funding of $1.03M over 4 rounds. …See details»
Investor Relations | Shuttle Pharmaceuticals
Apr 10, 2025 Email: [email protected]. Investor Relations. Lytham Partners, LLC Robert Blum Phone: 602-889-9700. Email: [email protected]. Transfer Agent. Vstock …See details»
Shuttle Pharmaceuticals | VentureRadar
Website: https://www.shuttlepharma.com/ Shuttle Pharmaceuticals is developing first-in-class therapies that are designed to cure cancer and improve the outcomes of ...See details»
Shuttle Pharma Provides Corporate Update and Reports 2024 …
Feb 27, 2025 GAITHERSBURG, Md., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a …See details»
Shuttle Pharma Provides Corporate Update and Reports 2024 …
Feb 26, 2025 Shuttle Pharmaceuticals 401 Professional Drive Suite 260 Gaithersburg, MD 20879. 240-430-4212 [email protected]See details»
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment
4 days ago [email protected]. Investor Contacts Lytham Partners, LLC Robert Blum 602-889-9700 [email protected] ...See details»
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with
Jan 8, 2024 Shuttle Pharmaceuticals Anatoly Dritschilo, M.D., [email protected] Investor Contacts Lytham Partners, LLC Robert Blum 602-889 …See details»